Niagen Bioscience (NAGE) Capital Leases (2011 - 2024)
Niagen Bioscience's (NAGE) quarterly Capital Leases came in at $2000.0 in Q3 2024, down 85.71% year-on-year from $14000.0 in Q4 2023, and down 66.67% on a QoQ basis from $6000.0 in Q2 2024.
Niagen Bioscience (NAGE) Capital Leases (2011 - 2024) Analysis & Trends
Niagen Bioscience (NAGE) has 12 years of Capital Leases data on file, last reported at $2000.0 in Q3 2024.
- On a quarterly basis, Capital Leases fell 85.71% year-over-year to $2000.0 in Q3 2024; TTM through Sep 2024 was $2000.0, a 85.71% decrease from a year earlier, with the FY2023 full-year figure at $12000.0, down 45.45% from the prior year.
- Capital Leases for Q3 2024 stood at $2000.0, down from $6000.0 in the prior quarter.
- Over the last five years, Capital Leases for NAGE reached as high as $36000.0 in Q1 2020 and fell as low as $2000.0 in Q3 2024.
- Historically, Capital Leases has averaged $16076.9 across 5 years, with a median of $14000.0 in 2023.
- Across the five-year window, Capital Leases gained 11.11% in 2020 and slumped 85.71% in 2024, its largest moves.
- Year by year, Capital Leases stood at $20000.0 in 2020, then slumped by 45.0% to $11000.0 in 2021, then jumped by 100.0% to $22000.0 in 2022, then sank by 45.45% to $12000.0 in 2023, then plunged by 83.33% to $2000.0 in 2024.
- Per Business Quant data, the three most recent Capital Leases figures were $2000.0 in Q3 2024, $6000.0 in Q2 2024, and $9000.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | 22,000.00 |
| Sep 30, 2021 | 11,000.00 |
| Jun 30, 2021 | 13,000.00 |
| Dec 31, 2020 | 20,000.00 |
| Jun 30, 2020 | 27,000.00 |
| Mar 31, 2020 | 36,000.00 |
| Dec 31, 2019 | 18,000.00 |
| Sep 30, 2019 | 70,000.00 |
| Jun 30, 2019 | 121,000.00 |
| Mar 31, 2019 | 94,000.00 |
| Dec 31, 2018 | 137,000.00 |
| Sep 30, 2018 | 178,000.00 |
| Jun 30, 2018 | 219,000.00 |